Budesonide/Formoterol Added to Tiotropium Is Well Tolerated and Reduces Risk of Severe Exacerbations in COPD Patients.

被引：0
|
作者：
Welte, T.
Hartman, L. [1 ]
Polanowski, T. [1 ]
Hernandez, P.
机构：
[1] AZ, Lund, Sweden
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6188
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Triple inhaled therapy of formoterol/glycopyrrolate/budesonide reduces the use of oral corticosteroids and antibiotics during COPD exacerbations in real-world conditions
    Calderon-Montero, A.
    Diez, J. de Miguel
    Gutierrez, R. de Simon
    Tellez, S. Campos
    Moreno, A. D. Chacon
    Aviles, R. Alonso
    Alonso, N. Gonzalez
    Solis, A. Montero
    Pardo, D. Escribano
    APyC Grp
    MEDICINA DE FAMILIA-SEMERGEN, 2025, 51 (04):
  • [42] Evaluating Characteristics Of Chronic Obstructive Pulmonary Disease (COPD) Patients New To Controller Treatment: Budesonide/formoterol Combination (bfc) Versus Tiotropium
    Williams, S.
    Trudo, F.
    Kern, D.
    Wessman, C.
    Tunceli, O.
    Zhou, S.
    Pethick, N.
    Elhefni, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [43] Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations (vol 108, pg 1153, 2014)
    Wedzicha, J. A.
    Singh, D.
    Vestbo, J.
    Paggiaro, P. L.
    Jones, P. W.
    Gonod, F. Bonnet
    Cohuet, G.
    Corradi, M.
    Vezzoli, S.
    Petruzzelli, S.
    Agusti, A.
    RESPIRATORY MEDICINE, 2015, 109 (03) : 434 - 435
  • [44] Transcriptomic footprint of COPD patients with well-defined frequent severe exacerbations
    Pascual, Sergi
    Puigdevall, Pau
    Casadevall, Carme
    Barreiro, Esther
    Castelo, Robert
    Gea Guiral, Joaquim
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [45] Tiotropium therapy and mortality risk in COPD patients: the most severe, the most protected?
    Sampablo, Italo
    Carone, Mauro
    Antoniu, Sabina Antonela
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (08) : 1439 - 1441
  • [46] Patients Treated with Budesonide/Formoterol Maintenance and Reliever Therapy Achieve Asthma (GINA) Control and Reduced Risk of Exacerbations
    Bateman, E. D.
    Harrison, T. W.
    Quirce, S.
    Ostlund, O.
    Sears, M. R.
    Eriksson, G. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [47] Aclidinium/formoterol Fixed-Dose Combination Improves Bronchodilation And Is Well Tolerated In Patients With COPD: Results From The Acliform/COPD Study
    Singh, D.
    Jones, P. W.
    Bateman, E. D.
    Korn, S.
    Serra, C.
    Molins, E.
    Caracta, C.
    Leselbaum, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [48] Dynamic hyperinflation is a risk factor for mortality and severe exacerbations in COPD patients
    Lorenzana, Isabel
    Galera, Raul
    Casitas, Raquel
    Martinez-Ceron, Elisabet
    Castillo, Maria Alejandra
    Alfaro, Enrique
    Cubillos-Zapata, Carolina
    Garcia-Rio, Francisco
    RESPIRATORY MEDICINE, 2024, 225
  • [49] Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations
    Papi, Alberto
    Petruzzelli, Stefano
    Vezzoli, Stefano
    Georges, George
    Fabbri, Leonardo M.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (04)
  • [50] Comparative Effectiveness Of Budesonide/formoterol Combination (bfc) And Tiotropium Bromide Among Chronic Obstructive Pulmonary Disease (COPD) Patients New To Controller Treatment
    Strange, C. B.
    Racketa, J.
    Kern, D. M.
    Williams, S. A.
    Tunceli, O.
    Zhou, S.
    Graham, E.
    Trudo, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345